Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk

Iván Ferraz-Amaro1, Alfonso Corrales2,3, Juan Carlos Quevedo-Abeledo4

  • 1Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. iferrazamaro@hotmail.com.

Insights

Cardiovascular risk in rheumatoid arthritis (RA) patients is often underestimated by standard charts. Disease activity, assessed via carotid ultrasound, significantly reclassifies RA patients to a very high cardiovascular risk category.

Area of Science:

  • Rheumatology
  • Cardiology
  • Medical Imaging

Background:

  • Systematic Coronary Risk Assessment (SCORE) algorithms often underestimate cardiovascular (CV) risk in rheumatoid arthritis (RA) patients.
  • Carotid ultrasound is a valuable tool for identifying high CV risk in RA patients.

Purpose of the Study:

  • To determine if specific RA disease features influence CV risk reclassification using SCORE charts and carotid ultrasound.
  • To identify predictors of CV risk reclassification in RA patients.

Main Methods:

  • 1279 RA patients without prior CV events, diabetes, or chronic kidney disease were analyzed.
  • Disease characteristics, CV comorbidity, SCORE, and carotid plaque presence were assessed.
  • Multivariable regression and predictive modeling were used to evaluate disease features' association with risk reclassification.

Main Results:

  • Carotid ultrasound revealed carotid plaque in 54% of patients, reclassifying them to very high CV risk.
  • Disease activity was significantly associated with CV risk reclassification.
  • A predictive model including dyslipidemia, hypertension, age >54, and DAS28-ESR ≥2.6 showed high discrimination for reclassification.

Conclusions:

  • Over half of RA patients are reclassified to very high CV risk by carotid ultrasound.
  • Disease activity is an independent predictor of this CV risk reclassification in RA.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
143
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
161
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
80
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
96
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
565